SS Innovations Bolsters Leadership and Training to Accelerate Global Adoption of Robotic Surgery

SS Innovations International Inc. (NASDAQ: SSII) is strengthening its position in the global surgical robotics market through a dual focus on leadership and education. The company recently announced the appointment of Sarah M. Romano as chief financial officer, a veteran medtech finance executive with over two decades of experience in capital markets and corporate finance. Romano has raised more than $100 million through public and private financings, a skill set that will be instrumental as SS Innovations advances its U.S. Food and Drug Administration (FDA) clearance efforts for its SSi Mantra robotic surgical system and pursues international expansion.

The appointment comes at a critical time for the company, which is working to bring its cost-effective robotic surgery platform to a broader global market. The SSi Mantra system is designed to be user-friendly and affordable, addressing a key barrier to the adoption of robotic surgery in many regions. With Romano's financial expertise, the company is better positioned to navigate the capital-intensive process of regulatory approval and commercial rollout.

In parallel with its leadership strengthening, SS Innovations is investing in the next generation of surgeons through its SS International Centre for Robotics Surgery. The center recently graduated its first cardiac robotic training class, comprising 33 healthcare professionals from seven countries. This initiative is part of a broader strategy to pair advanced technology with comprehensive physician education, ensuring that surgeons are well-prepared to utilize the SSi Mantra system effectively.

By combining technological innovation with training programs, SS Innovations aims to accelerate the adoption of robotic surgery, particularly in cardiac procedures. The company's vision is to make the benefits of robotic surgery accessible to a larger segment of the global population, a mission that aligns with the growing demand for minimally invasive surgical options.

For more details on this development, visit the full article at https://ibn.fm/lTCqR. For the latest news and updates on SS Innovations, see the company's newsroom at https://ibn.fm/SSII.

This strategic combination of financial leadership and educational investment signals a mature approach to scaling a medical technology enterprise. As SS Innovations continues to expand its global footprint, the impact on the healthcare industry could be significant, potentially lowering the cost of robotic surgery and increasing its availability in underserved markets.